Technology | Stents Bare Metal | December 09, 2015

Medinol Begins U.S. Commercialization of New Coronary Stent

NIRxcell CoCr Stent System first product launched from new U.S. headquarters

December 9, 2015 — Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the launch of the NIRxcell CoCr Stent System.

During the recent 2015 Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco, Medinol Ltd. hosted a satellite symposium, "The BioNIR eDES: The Role of Uniformity in Stent Design to Minimize Restenosis", where a physician panel discussed the key attributes of the NIRxcell System and the Medinol eDES Coronary Stent System (in trials, not FDA/CE Mark approved). Physician faculty included David E. Kandzari, M.D., Piedmont Heart Institute; Jim Zidar, M.D., North Carolina Heart and Vascular; Rajiv Jauhar, M.D., North Shore University Medical Center; Peter Smits, M.D., Maasstad Ziekenhuis, Rotterdam, the Netherlands; and Shmuel Banai, M.D., The Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Discussion highlighted key product features and emphasized the design of the BIONICS/NIREUS clinical trials that have recently completed enrollment. 

Kandzari commented, "The delivery system is unlike in any other product on the market" and Medinol's approach to trial design "was entirely unlike any other pivotal trial as it included a 'more comers' patient population."

On an annual basis, approximately 800,000 patients undergo coronary stenting procedures in the United States. Healthcare providers continue to look for novel, effective and efficient solutions to treat their patients.

For more information: www.medinol.com

Related Content

News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
Subscribe Now